Cart
sales@molnova.com
Brefeldin A
CAS No. 20350-15-6
Brefeldin A( Ascotoxin | BFA | Cyanein | Decumbin | Nectrolide | NSC 56310 | Synergisidin )
Catalog No. M13166 CAS No. 20350-15-6
Brefeldin A is a lactone antibiotic and ATPase inhibitor for protein transport with IC50 of 0.2 μM in HCT 116 cells, induces Y cell differentiation and apoptosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 46 | In Stock |
|
| 2MG | 32 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 55 | In Stock |
|
| 50MG | 184 | In Stock |
|
| 100MG | 335 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBrefeldin A
-
NoteResearch use only, not for human use.
-
Brief DescriptionBrefeldin A is a lactone antibiotic and ATPase inhibitor for protein transport with IC50 of 0.2 μM in HCT 116 cells, induces Y cell differentiation and apoptosis.
-
DescriptionBrefeldin A is a lactone antibiotic and ATPase inhibitor for protein transport with IC50 of 0.2 μM in HCT 116 cells, induces Y cell differentiation and apoptosis.
-
In Vitro——
-
In Vivo——
-
SynonymsAscotoxin | BFA | Cyanein | Decumbin | Nectrolide | NSC 56310 | Synergisidin
-
PathwayEndocrinology/Hormones
-
TargetATPase
-
RecptorATPase (HCT 116)
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number20350-15-6
-
Formula Weight280.36
-
Molecular FormulaC16H24O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 4 mg/mL (14.26 mM)
-
SMILESC[C@H]1CCC/C=C/[C@@H]2C[C@@H](C[C@H]2[C@@H](/C=C/C(=O)O1)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhu JW, et al. Bioorg Med Chem. 2000, 8(2), 455-463.
molnova catalog
related products
-
NC-1300-B
NC-1300-B inhibits H(+)-K(+)-ATPase and is used in the study of gastric ulcers.
-
Mtb ATP synthase-IN-...
Mtb ATP synthase-IN-1 (compound 6ab) is a potent inhibitor of Mycobacterium tuberculosis (Mtb) ATP synthase (MIC = 0.452-0.499 μg/mL) that can be used in anti-mycobacterium research, showing low cytotoxicity (Vero IC 50 > 64 μg/mL) and acceptable oral bioavailability with good metabolic stability.
-
KM 91104
KM 91104 is a cell permeable inhibitor of V-ATPase. KM91104 specifically targets the interaction between V-ATPase subunit A3 and subunit B2.
